Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Marlene Debel is EVP & Chief Risk Officer at MetLife. OQRO lists 14 transactions filed with the SEC under this name, the latest on Sep 2, 2026, each linked to the official Form 4.
EVP & Chief Risk Officer
Disclosures on record
14
Companies involved
2
As of the latest filing on , Marlene Debel reported holding 150,350 shares of MetLife (MET), worth about $15.4M at the last close of $103 (Nov 13, 2026). Holdings are also on file at Raymond James Financial (RJF); together they are worth about $16.9M. In the last 12 months, Marlene Debel sold $1.74M in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| MetLife MET | 150,350 | 150K direct | $103 | $15.4M | Aug 31, 2026 |
| Raymond James Financial RJF | 8,820 | 8,820 direct | $169 | $1.49M | Feb 19, 2026 |
Is this Marlene Debel’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
MetLifeMET
11 disclosures · Dec 2024 – Sep 2026 · 2 sold
Aug 31, 20264,030disclosed Sep 2
DetailsOfficial recordJun 1, 2026Sold~$1.74Mdisclosed Jun 3
DetailsOfficial recordJun 1, 202611Kdisclosed Jun 3
DetailsOfficial recordJun 1, 202611Kdisclosed Jun 3
DetailsOfficial recordJun 1, 202611Kdisclosed Jun 3
DetailsOfficial recordJun 1, 202611Kdisclosed Jun 3
DetailsOfficial recordMar 2, 20264,133disclosed Mar 4
DetailsOfficial recordFeb 24, 202615Kdisclosed Feb 26
DetailsOfficial recordFeb 24, 202615Kdisclosed Feb 26
DetailsOfficial recordFeb 24, 20265,624disclosed Feb 26
DetailsOfficial recordDec 13, 2024Sold~$1.89Mdisclosed Dec 17
DetailsOfficial recordRaymond James FinancialRJF
3 disclosures · Feb 2026
Feb 19, 20261,303disclosed Feb 23
DetailsOfficial recordFeb 19, 20261,253disclosed Feb 23
DetailsOfficial recordFeb 19, 20261,253disclosed Feb 23
DetailsOfficial recordOn the latest SEC Form 4, dated Aug 31, 2026, Marlene Debel reported holding 150,350 shares of MetLife (MET). At the last close of $103 on Nov 13, 2026, that is about $15.4M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Marlene Debel reported 1 open-market sale worth $1.74M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Marlene Debel has no open-market purchase on record since 2021. Sales in 5 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
MetLife (MET), from 2021 to 2026: 0 purchases and 5 sales.
Marlene Debel has no open-market purchase on record since 2021. Sales in 5 of the 6 years since 2021.
Marlene Debel reported 0 open-market purchases and 5 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $1.74M1×1 trade |
| 2024 | — | $1.89M1×1 trade |
| 2023 | — | $593K1×1 trade |
| 2022 |
$274K1×1 trade |
| 2021 | — | $710K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Marlene Debel reported 0 open-market purchases and 5 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
